If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.
GW Pharmaceuticals (Nasdaq: GWPH) has been granted orphan drug designation by the US Food and Drug Administration…
EuropeGW PharmaceuticalsNorth AmericaPharmaceuticalRare diseasesRegulationUKUSA
Our latest news direct to your inbox
Back to top